Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Neoplasm With Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00083109
What this trial is testing

Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer

Who this might be right for
Recurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT01566747
What this trial is testing

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5

Who this might be right for
Renal Cell Carcinoma
Cancer Trials Ireland 43
Testing effectiveness (Phase 2)Study completedNCT00520403
What this trial is testing

Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.

Who this might be right for
Renal Cell Cancer
Hoffmann-La Roche 25
Testing effectiveness (Phase 2)Study completedNCT01743469
What this trial is testing

A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers

Who this might be right for
Advanced or Metastatic Hepatocellular CancerAdvanced or Metastatic Ovarian CancerMetastatic Renal Cell Cancer+1 more
Ipsen 201
Testing effectiveness (Phase 2)Ended earlyNCT04955743
What this trial is testing

Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma

Who this might be right for
MelanomaRenal Cell CarcinomaBrain Metastases+4 more
Yale University 18
Testing effectiveness (Phase 2)Ended earlyNCT03024437
What this trial is testing

Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Metastatic CancerRenal Cancer
Roberto Pili 31
Testing effectiveness (Phase 2)Ended earlyNCT00089102
What this trial is testing

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Medical University of South Carolina 9
Testing effectiveness (Phase 2)Study completedNCT00077129
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group 22
Testing effectiveness (Phase 2)WithdrawnNCT00040989
What this trial is testing

BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer

Who this might be right for
Stage IV Renal Cell CancerRecurrent Renal Cell Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03075423
What this trial is testing

Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Goethe University 316
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Testing effectiveness (Phase 2)Study completedNCT00365768
What this trial is testing

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Columbia University 56
Testing effectiveness (Phase 2)UnknownNCT06221774
What this trial is testing

Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

Who this might be right for
Clear Cell Renal CarcinomaUrothelial CarcinomaMetastatic Castration-resistant Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 42
Early research (Phase 1)Looking for participantsNCT06234605
What this trial is testing

HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
HiberCell, Inc. 80
Not applicableUnknownNCT05816642
What this trial is testing

Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
RenJi Hospital 500
Testing effectiveness (Phase 2)Ended earlyNCT01961583
What this trial is testing

[18F]Fluciclatide PET Imaging of Pazopanib Response

Who this might be right for
Kidney Neoplasm
Asan Medical Center 12
Not applicableStudy completedNCT03699579
What this trial is testing

Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC

Who this might be right for
Renal Cell Carcinoma MetastaticRenal Cell Carcinoma
Ipsen 28
Early research (Phase 1)Looking for participantsNCT07128680
What this trial is testing

Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+3 more
City of Hope Medical Center 33
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Testing effectiveness (Phase 2)Ended earlyNCT00098618
What this trial is testing

Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaPapillary Renal Cell CarcinomaRecurrent Renal Cell Cancer+2 more
National Cancer Institute (NCI) 40
Next Page